These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1830582)

  • 21. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.
    Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE
    Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of type-II interleukin-1 receptors. Heterogeneity of B-cell interleukin-1 binding created by dimerization of type-II interleukin-1 receptors.
    Cronkhite RI; Lobick JJ; Plate JM
    Hum Immunol; 1993 Feb; 36(2):128-36. PubMed ID: 8463123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of IL-1 receptors on human and murine neutrophils. Relevance to IL-1-mediated effects in inflammation.
    Parker KP; Benjamin WR; Kaffka KL; Kilian PL
    J Immunol; 1989 Jan; 142(2):537-42. PubMed ID: 2521349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
    Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
    Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a specific receptor for interleukin-1 on rat bone marrow cells.
    Mizuno K; Nakai S; Ohmoto Y; Hirai Y
    FEBS Lett; 1989 Oct; 257(1):27-30. PubMed ID: 2530111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist.
    Barak V; Peritt D; Flechner I; Yanai P; Halperin T; Treves AJ; Dinarello CA
    Lymphokine Cytokine Res; 1991 Dec; 10(6):437-42. PubMed ID: 1839505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HepG2 cells predominantly express the type II interleukin 1 receptor (biochemical and molecular characterization of the IL-1 receptor).
    Giri JG; Robb R; Wong WL; Horuk R
    Cytokine; 1992 Jan; 4(1):18-23. PubMed ID: 1319762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a soluble interleukin-8 inhibitor in the supernatant of polymorphonuclear leukocytes.
    Kemény L; Szolnoky G; Kenderessy AS; Gyulai R; Kiss M; Michel G; Nagy K; Ruzicka T; Dobozy A
    Immunol Lett; 1998 Nov; 64(1):23-9. PubMed ID: 9865598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line.
    Dower SK; Call SM; Gillis S; Urdal DL
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1060-4. PubMed ID: 2937055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.
    Cassatella MA; Meda L; Gasperini S; Calzetti F; Bonora S
    J Exp Med; 1994 May; 179(5):1695-9. PubMed ID: 8163946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human recombinant interleukin-1 receptor antagonist inhibits lymphocyte blastogenesis induced by concanavalin A. Restorative effect of hrIL-1.
    Conti P; Reale M; Panara MR; Barbacane RC; Bongrazio M; Dempsey RA
    FEBS Lett; 1991 Jul; 286(1-2):137-41. PubMed ID: 1830851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A soluble form of the interleukin-1 receptor produced by a human B cell line.
    Symons JA; Duff GW
    FEBS Lett; 1990 Oct; 272(1-2):133-6. PubMed ID: 1699802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and identification of interleukin-1 receptors on bovine fibroblasts.
    Lederer J; Czuprynski C
    Mol Immunol; 1993 Feb; 30(2):191-6. PubMed ID: 8429834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase C-linked inactivation of the interleukin-1 receptor in a human transformed B-cell line.
    Horuk R; Gross JL
    Biochim Biophys Acta; 1990 Apr; 1052(1):173-8. PubMed ID: 2138916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils.
    Marie C; Pitton C; Fitting C; Cavaillon JM
    Cytokine; 1996 Feb; 8(2):147-51. PubMed ID: 8777273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
    Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells.
    Symons JA; Eastgate JA; Duff GW
    Cytokine; 1990 May; 2(3):190-8. PubMed ID: 2151765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
    Vannier E; Miller LC; Dinarello CA
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4076-80. PubMed ID: 1533284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.